Eli Lilly launches oral weight-loss drug Mounjaro in UK pharmacies
LLY Lilly(Eli) & Co
$1255.40 +0.88%
View chart & analysis → - 1Eli Lilly (LLY) has launched Mounjaro, its once-daily oral weight-management and diabetes drug, in UK pharmacies.
- 2Following MHRA approval this month, it will be available on private prescription from Monday for patients with a BMI of 30 or above, among others.
- 3The UK is the first European country to approve it, the NHS does not provide it, and the launch strengthens Lilly's position following Mounjaro and Zepbound.
This 3-line summary is compiled from the report below.
Proactive +1 View original ↗
오늘의 AI 픽 5종목, 무료로 전부 공개합니다숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다